查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1888673

急性呼吸道疾病診斷市場規模、佔有率和趨勢分析報告：按檢測方法、病原體、最終用途、地區和細分市場預測（2025-2033 年）

Acute Respiratory Disease Diagnostics Market Size, Share & Trends Analysis Report By Test, By Pathogen, By End-use, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

急性呼吸系統疾病診斷市場摘要

2024年全球急性呼吸系統疾病診斷市場規模估計為54.9億美元，預計2033年將達到107.1億美元。

預計從 2025 年到 2033 年，該市場將以 7.01% 的複合年成長率成長。推動市場成長的關鍵因素包括呼吸系統疾病負擔加重、診斷技術的進步以及對早期檢測和分散式檢查需求的不斷成長。

根據健康指標與評估研究所 (IHME) 2023 年 4 月發布的報告，慢性呼吸道疾病 (CRD) 是全球第三大死因。此外，人口老化、醫療基礎設施擴建、發展中市場投資增加、政府主導的各項措施、公共衛生項目以及資金投入等人口結構變化正在推動市場成長。隨著全球老年人口比例的不斷上升，呼吸系統疾病病例數量也在增加，因為老化通常伴隨著肺功能下降和免疫系統減弱。這種人口結構變化顯著增加了慢性及急性感染疾病（包括肺炎、慢性阻塞性肺病(COPD) 和流感等合併症）的風險。因此，人口老化推動了對快速、精準診斷工具的需求，旨在實現早期發現、及時介入並改善臨床療效。

同時，新興經濟體的醫療衛生基礎設施正在迅速擴張，為採用新的診斷技術奠定了堅實的基礎。亞太、拉丁美洲和中東各國正大力投資醫療衛生現代化、檢查室自動化和創新醫療設備的研發。各國政府和私人醫療機構正透過公私合營，加強診斷能力，建立專門的呼吸系統檢測中心，並引進就地檢驗。這些措施將改善診斷服務的可近性，加快檢測速度，並加強都市區地區的疾病防治。

此外，政府計畫和國際公共衛生舉措在支持全球診斷生態系統方面發揮著至關重要的作用。世界衛生組織、全球基金和各國衛生署為加強呼吸系統疾病監測、資助研究以及確保公平獲取關鍵診斷材料所做的努力表明，全球診斷界正在攜手合作，以增強診斷能力並改善公眾健康。不斷變化的報銷環境、公眾意識宣傳活動、全球創新戰略資金以及合作研究正在重塑全球分子和數位診斷的格局。這些努力旨在透過早期、準確和可近的診斷來減輕急性呼吸系統疾病的負擔，建立一個完善的生態系統，並最終改善公眾健康。

目錄

第1章 急性呼吸系統疾病診斷市場：調查方法與範圍

2. 急性呼吸系統疾病診斷市場：執行摘要

  • 市場概覽
  • 檢查概述
  • 病原體概述
  • 最終用途概述
  • 競爭格局概述

3. 急性呼吸系統疾病診斷市場的變數、趨勢和範圍

  • 市場區隔和範圍
  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
  • 市場促進因素分析
    • 呼吸系統疾病負擔日益加重
    • 診斷技術的進步
    • 對早期檢測和分散式檢查的需求日益成長
  • 市場限制因素分析
    • 先進診斷技術高成本
    • 意識薄弱且檢測不足
    • 基礎設施和熟練勞動力方面的限制
  • 波特五力分析
  • PESTLE分析
  • 管道分析

第4章 急性呼吸系統疾病診斷市場：依檢測方法分類的估算與趨勢分析

  • 急性呼吸道疾病診斷市場：按檢測方法分類的趨勢分析
  • 分子診斷
    • PCR
    • INAAT
  • 基於抗原的快速檢測
  • 血清學檢測（IgM/IgG）
  • 症候群特異性呼吸道檢測
  • 其他新興技術（基於 CRISPR 的技術、奈米孔定序、人工智慧驅動的成像）

第5章 急性呼吸道疾病診斷市場：依病原體分類的估算與趨勢分析

  • 急性呼吸道疾病診斷市場：依病原體分類的差異分析
  • 病毒感染疾病
    • 甲型和乙型流感
    • 呼吸道融合細胞病毒（RSV）
    • SARS-CoV-2
    • 其他
  • 細菌感染疾病
    • 肺炎球菌
    • 流感細菌
    • 肺炎黴漿菌
    • 百日咳桿菌
  • 其他

第6章：急性呼吸系統疾病診斷市場：依最終用途分類的估算與趨勢分析

  • 急性呼吸系統疾病診斷市場：依最終用途分類的差異分析
  • 醫院和診所
  • 診斷與參考檢查室
  • 居家檢測
  • 其他（公共衛生、監測實驗室）

7. 急性呼吸系統疾病診斷市場：區域業務分析

  • 區域市場概覽
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東和非洲

第8章 競爭情勢

  • 公司分類
  • 策略規劃
    • 新產品發布
    • 合夥
    • 獲得
    • 合資
    • 資金籌措
  • 主要企業市佔率分析（2024 年）
  • 公司熱力圖分析
  • 公司簡介
    • F. Hoffmann La-Roche
    • Abbott Laboratories
    • Quidel Corporation
    • Becton, Dickinson and Company（BD）
    • Thermo Fisher Scientific, Inc.
    • Siemens Healthineers
    • Bio-Rad Laboratories
    • Luminex Corporation
    • BioMerieux
    • Meridian Bioscience
    • Fujirebio Diagnostics
    • Cepheid
    • Lumos Diagnostics
Product Code: GVR-4-68040-812-9

Acute Respiratory Disease Diagnostics Market Summary

The global acute respiratory disease diagnostics market size was estimated at USD 5.49 billion in 2024 and is projected to reach USD 10.71 billion by 2033, growing at a CAGR of 7.01% from 2025 to 2033. Some of the major factors driving the market are rising disease burden of respiratory conditions, advancements in diagnostic technologies, and increasing demand for early detection & decentralized testing.

According to the Institute for Health Metrics and Evaluation (IHME) in April 2023, chronic respiratory diseases (CRDs) are the third leading cause of death globally. Furthermore, the market growth is driven by the ageing demographic shift, increased healthcare infrastructure & investment in developing markets, government initiatives, public health programs & funding. The rise in the proportion of older people globally has led to an increase in cases of respiratory disorders, as older age is often associated with decreased lung capacity and decreased immune functioning. This demographic shift introduces significant risk for the development of chronic and acute infections with co-morbidities, including pneumonia, chronic obstructive pulmonary disease (COPD), and influenza. As a result, there is an increasing demand for rapid and accurate diagnostic tools for early detection, timely intervention, and improved clinical outcomes among the aging demographic.

Simultaneously, the healthcare infrastructure in emerging economies is rapidly expanding, providing a solid base for the adoption of new diagnostic techniques. Countries in the Asia-Pacific, Latin America, and Middle East regions are seeing significant investments in the modernization of healthcare, laboratory automation, and the development of innovative devices. Governments and private healthcare providers are collaborating to enhance diagnostic capacity through public-private partnerships, the establishment of specialized respiratory testing centers, and the implementation of point-of-care testing. These efforts will lead to increased access to diagnostic services, shorter turnaround times, and enhanced disease management in both urban and rural areas.

In addition, government programs and international public health initiatives play a crucial role in supporting the global diagnostic ecosystem. Existing efforts by the WHO, the Global Fund, and the Ministries of Health of various countries to enhance surveillance of respiratory diseases, fund research, and provide equitable access to critical diagnostic supplies indicate that the global diagnostic community is working collaboratively to strengthen diagnostic capabilities worldwide and improve public health. Changes in reimbursement environments, public awareness campaigns, global strategic funding for innovations, and collaborative research efforts are reshaping global adherence to molecular and digital diagnostics. Overall, these aims aim to provide an ecosystem and ultimately improve public health by reducing the burden of acute respiratory disease through early, accurate, and accessible diagnostics.

Global Acute Respiratory Disease Diagnostics Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global acute respiratory disease diagnostics market based on test, pathogen, end-use, and region:

  • Test Outlook (Revenue, USD Million, 2021 - 2033)
  • Molecular Diagnostics
    • PCR
    • INAAT
  • Antigen-based Rapid Tests
  • Serological Tests (IgM/IgG)
  • Syndromic Respiratory Panels
  • Other Emerging Technologies (CRISPR-based, Nanopore Sequencing, AI-driven Imaging)
  • Pathogen Outlook (Revenue, USD Million, 2021 - 2033)
  • Viral Infections
    • Influenza A & B
    • Respiratory Syncytial Virus (RSV)
    • SARS-CoV-2
    • Others
  • Bacterial Infections
    • Streptococcus pneumoniae
    • Haemophilus influenzae
    • Mycoplasma pneumoniae
    • Bordetella pertussis
  • Others
  • End-use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals & Clinics
  • Diagnostic and Reference Labs
  • Home Testing
  • Others (Public health, surveillance labs)
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Acute Respiratory Disease Diagnostics Market: Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Segment Definitions
      • 1.1.1.1. Test Method
      • 1.1.1.2. Pathogen Segment
      • 1.1.1.3. End Use Segment
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Objectives
    • 1.4.1. Objective - 1
    • 1.4.2. Objective - 2
    • 1.4.3. Objective - 3
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Secondary Sources
    • 1.6.4. Primary Research
  • 1.7. Information or Data Analysis
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity Flow Analysis
  • 1.10. List of Secondary Sources
  • 1.11. List of Abbreviations

Chapter 2. Acute Respiratory Disease Diagnostics Market: Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Test Snapshot
  • 2.3. Pathogen Snapshot
  • 2.4. End Use Snapshot
  • 2.5. Competitive Landscape Snapshot

Chapter 3. Acute Respiratory Disease Diagnostics Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Dynamics
  • 3.4. Market Drivers Analysis
    • 3.4.1. Rising disease burden of respiratory conditions
    • 3.4.2. Advancements in diagnostic technologies
    • 3.4.3. Increasing demand for early detection and decentralised testing
  • 3.5. Market Restraint Analysis
    • 3.5.1. High cost of advanced diagnostics
    • 3.5.2. Limited awareness and under-screening
    • 3.5.3. Infrastructure & skilled workforce constraints
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis
  • 3.8. Pipeline Analysis

Chapter 4. Acute Respiratory Disease Diagnostics Market: Test Estimates & Trend Analysis

  • 4.1. Acute Respiratory Disease Diagnostics Market: Test Movement Analysis
  • 4.2. Molecular Diagnostics
    • 4.2.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.2.2. PCR
      • 4.2.2.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.2.3. INAAT
      • 4.2.3.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.3. Antigen-based Rapid Tests
    • 4.3.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4. Serological Tests (IgM/IgG)
    • 4.4.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Syndromic Respiratory Panels
    • 4.5.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Other Emerging Technologies (CRISPR-based, Nanopore Sequencing, AI-driven Imaging)
    • 4.6.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Acute Respiratory Disease Diagnostics Market: Pathogen Estimates & Trend Analysis

  • 5.1. Acute Respiratory Disease Diagnostics Market: Pathogen Movement Analysis
  • 5.2. Viral Infections
    • 5.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.2.2. Influenza A & B
      • 5.2.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.2.3. Respiratory Syncytial Virus (RSV)
      • 5.2.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.2.4. SARS-CoV-2
      • 5.2.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.2.5. Others
      • 5.2.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.3. Bacterial Infections
    • 5.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.3.2. Streptococcus pneumoniae
      • 5.3.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.3.3. Haemophilus influenzae
      • 5.3.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.3.4. Mycoplasma pneumoniae
      • 5.3.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.3.5. Bordetella pertussis
      • 5.3.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4. Others
    • 5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Acute Respiratory Disease Diagnostics Market: End Use Estimates & Trend Analysis

  • 6.1. Acute Respiratory Disease Diagnostics Market: End Use Movement Analysis
  • 6.2. Hospitals & Clinics
    • 6.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.3. Diagnostic and Reference Labs
    • 6.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4. Home Testing
    • 6.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Others (Public health, surveillance labs)
    • 6.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Acute Respiratory Disease Diagnostics Market: Regional Business Analysis

  • 7.1. Regional Market Snapshot
  • 7.2. North America
    • 7.2.1. North America Acute Respiratory Disease Diagnostics Market Estimates and Forecast, 2021 - 2033 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. U.S. Acute Respiratory Disease Diagnostics Market, 2021 - 2033 (USD Million)
      • 7.2.2.2. Key Country Dynamics
      • 7.2.2.3. Regulatory Framework
      • 7.2.2.4. Reimbursement Scenario
      • 7.2.2.5. Competitive Scenario
    • 7.2.3. Canada
      • 7.2.3.1. Canada Acute Respiratory Disease Diagnostics Market, 2021 - 2033 (USD Million)
      • 7.2.3.2. Key Country Dynamics
      • 7.2.3.3. Regulatory Framework
      • 7.2.3.4. Reimbursement Scenario
      • 7.2.3.5. Competitive Scenario
    • 7.2.4. Mexico
      • 7.2.4.1. Mexico Acute Respiratory Disease Diagnostics Market, 2021 - 2033 (USD Million)
      • 7.2.4.2. Key Country Dynamics
      • 7.2.4.3. Regulatory Framework
      • 7.2.4.4. Reimbursement Scenario
      • 7.2.4.5. Competitive Scenario
  • 7.3. Europe
    • 7.3.1. Europe Acute Respiratory Disease Diagnostics Market, 2021 - 2033 (USD Million)
    • 7.3.2. UK
      • 7.3.2.1. UK Acute Respiratory Disease Diagnostics Market, 2021 - 2033 (USD Million)
      • 7.3.2.2. Key Country Dynamics
      • 7.3.2.3. Regulatory Framework
      • 7.3.2.4. Reimbursement Scenario
      • 7.3.2.5. Competitive Scenario
    • 7.3.3. Germany
      • 7.3.3.1. Germany Acute Respiratory Disease Diagnostics Market, 2021 - 2033 (USD Million)
      • 7.3.3.2. Key Country Dynamics
      • 7.3.3.3. Regulatory Framework
      • 7.3.3.4. Reimbursement Scenario
      • 7.3.3.5. Competitive Scenario
    • 7.3.4. Spain
      • 7.3.4.1. Spain Acute Respiratory Disease Diagnostics Market, 2021 - 2033 (USD Million)
      • 7.3.4.2. Key Country Dynamics
      • 7.3.4.3. Regulatory Framework
      • 7.3.4.4. Reimbursement Scenario
      • 7.3.4.5. Competitive Scenario
    • 7.3.5. France
      • 7.3.5.1. France Acute Respiratory Disease Diagnostics Market, 2021 - 2033 (USD Million)
      • 7.3.5.2. Key Country Dynamics
      • 7.3.5.3. Regulatory Framework
      • 7.3.5.4. Reimbursement Scenario
      • 7.3.5.5. Competitive Scenario
    • 7.3.6. Italy
      • 7.3.6.1. Italy Acute Respiratory Disease Diagnostics Market, 2021 - 2033 (USD Million)
      • 7.3.6.2. Key Country Dynamics
      • 7.3.6.3. Regulatory Framework
      • 7.3.6.4. Reimbursement Scenario
      • 7.3.6.5. Competitive Scenario
    • 7.3.7. Denmark
      • 7.3.7.1. Denmark Acute Respiratory Disease Diagnostics Market, 2021 - 2033 (USD Million)
      • 7.3.7.2. Key Country Dynamics
      • 7.3.7.3. Regulatory Framework
      • 7.3.7.4. Reimbursement Scenario
      • 7.3.7.5. Competitive Scenario
    • 7.3.8. Sweden
      • 7.3.8.1. Sweden Acute Respiratory Disease Diagnostics Market, 2021 - 2033 (USD Million)
      • 7.3.8.2. Key Country Dynamics
      • 7.3.8.3. Regulatory Framework
      • 7.3.8.4. Reimbursement Scenario
      • 7.3.8.5. Competitive Scenario
    • 7.3.9. Norway
      • 7.3.9.1. Norway Acute Respiratory Disease Diagnostics Market, 2021 - 2033 (USD Million)
      • 7.3.9.2. Key Country Dynamics
      • 7.3.9.3. Regulatory Framework
      • 7.3.9.4. Reimbursement Scenario
      • 7.3.9.5. Competitive Scenario
  • 7.4. Asia Pacific
    • 7.4.1. Asia-Pacific Acute Respiratory Disease Diagnostics Market, 2021 - 2033 (USD Million)
    • 7.4.2. Japan
      • 7.4.2.1. Japan Acute Respiratory Disease Diagnostics Market, 2021 - 2033 (USD Million)
      • 7.4.2.2. Key Country Dynamics
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. Reimbursement Scenario
      • 7.4.2.5. Competitive Scenario
    • 7.4.3. China
      • 7.4.3.1. China Acute Respiratory Disease Diagnostics Market, 2021 - 2033 (USD Million)
      • 7.4.3.2. Key Country Dynamics
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. Reimbursement Scenario
      • 7.4.3.5. Competitive Scenario
    • 7.4.4. India
      • 7.4.4.1. India Acute Respiratory Disease Diagnostics Market, 2021 - 2033 (USD Million)
      • 7.4.4.2. Key Country Dynamics
      • 7.4.4.3. Regulatory Framework
      • 7.4.4.4. Reimbursement Scenario
      • 7.4.4.5. Competitive Scenario
    • 7.4.5. South Korea
      • 7.4.5.1. South Korea Acute Respiratory Disease Diagnostics Market, 2021 - 2033 (USD Million)
      • 7.4.5.2. Key Country Dynamics
      • 7.4.5.3. Regulatory Framework
      • 7.4.5.4. Reimbursement Scenario
      • 7.4.5.5. Competitive Scenario
    • 7.4.6. Thailand
      • 7.4.6.1. Thailand Acute Respiratory Disease Diagnostics Market, 2021 - 2033 (USD Million)
      • 7.4.6.2. Key Country Dynamics
      • 7.4.6.3. Regulatory Framework
      • 7.4.6.4. Reimbursement Scenario
      • 7.4.6.5. Competitive Scenario
    • 7.4.7. Australia
      • 7.4.7.1. Australia Acute Respiratory Disease Diagnostics Market, 2021 - 2033 (USD Million)
      • 7.4.7.2. Key Country Dynamics
      • 7.4.7.3. Regulatory Framework
      • 7.4.7.4. Reimbursement Scenario
      • 7.4.7.5. Competitive Scenario
  • 7.5. Latin America
    • 7.5.1. Latin America Acute Respiratory Disease Diagnostics Market, 2021 - 2033 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Brazil Acute Respiratory Disease Diagnostics Market, 2021 - 2033 (USD Million)
      • 7.5.2.2. Key Country Dynamics
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Reimbursement Scenario
      • 7.5.2.5. Competitive Scenario
    • 7.5.3. Argentina
      • 7.5.3.1. Argentina Acute Respiratory Disease Diagnostics Market, 2021 - 2033 (USD Million)
      • 7.5.3.2. Key Country Dynamics
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Reimbursement Scenario
      • 7.5.3.5. Competitive Scenario
  • 7.6. MEA
    • 7.6.1. MEA Acute Respiratory Disease Diagnostics Market, 2021 - 2033 (USD Million)
    • 7.6.2. South Africa
      • 7.6.2.1. South Africa Acute Respiratory Disease Diagnostics Market, 2021 - 2033 (USD Million)
      • 7.6.2.2. Key Country Dynamics
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Reimbursement Scenario
      • 7.6.2.5. Competitive Scenario
    • 7.6.3. Saudi Arabia
      • 7.6.3.1. Saudi Arabia Acute Respiratory Disease Diagnostics Market, 2021 - 2033 (USD Million)
      • 7.6.3.2. Key Country Dynamics
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Reimbursement Scenario
      • 7.6.3.5. Competitive Scenario
    • 7.6.4. UAE
      • 7.6.4.1. UAE Acute Respiratory Disease Diagnostics Market, 2021 - 2033 (USD Million)
      • 7.6.4.2. Key Country Dynamics
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. Reimbursement Scenario
      • 7.6.4.5. Competitive Scenario
    • 7.6.5. Kuwait
      • 7.6.5.1. Kuwait Acute Respiratory Disease Diagnostics Market, 2021 - 2033 (USD Million)
      • 7.6.5.2. Key Country Dynamics
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. Reimbursement Scenario
      • 7.6.5.5. Competitive Scenario

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Strategy Mapping
    • 8.2.1. New Product Launch
    • 8.2.2. Partnerships
    • 8.2.3. Acquisition
    • 8.2.4. Collaboration
    • 8.2.5. Funding
  • 8.3. Key Company Market Share Analysis, 2024
  • 8.4. Company Heat Map Analysis
  • 8.5. Company Profiles
    • 8.5.1. F. Hoffmann La-Roche
      • 8.5.1.1. Overview
      • 8.5.1.2. Financial Performance
      • 8.5.1.3. Product Benchmarking
      • 8.5.1.4. Strategic Initiatives
    • 8.5.2. Abbott Laboratories
      • 8.5.2.1. Overview
      • 8.5.2.2. Financial Performance
      • 8.5.2.3. Product Benchmarking
      • 8.5.2.4. Strategic Initiatives
    • 8.5.3. Quidel Corporation
      • 8.5.3.1. Overview
      • 8.5.3.2. Financial Performance
      • 8.5.3.3. Product Benchmarking
      • 8.5.3.4. Strategic Initiatives
    • 8.5.4. Becton, Dickinson and Company (BD)
      • 8.5.4.1. Overview
      • 8.5.4.2. Financial Performance
      • 8.5.4.3. Product Benchmarking
      • 8.5.4.4. Strategic Initiatives
    • 8.5.5. Thermo Fisher Scientific, Inc.
      • 8.5.5.1. Overview
      • 8.5.5.2. Financial Performance
      • 8.5.5.3. Product Benchmarking
      • 8.5.5.4. Strategic Initiatives
    • 8.5.6. Siemens Healthineers
      • 8.5.6.1. Overview
      • 8.5.6.2. Financial Performance
      • 8.5.6.3. Product Benchmarking
      • 8.5.6.4. Strategic Initiatives
    • 8.5.7. Bio-Rad Laboratories
      • 8.5.7.1. Overview
      • 8.5.7.2. Financial Performance
      • 8.5.7.3. Product Benchmarking
      • 8.5.7.4. Strategic Initiatives
    • 8.5.8. Luminex Corporation
      • 8.5.8.1. Overview
      • 8.5.8.2. Financial Performance
      • 8.5.8.3. Product Benchmarking
      • 8.5.8.4. Strategic Initiatives
    • 8.5.9. BioMerieux
      • 8.5.9.1. Overview
      • 8.5.9.2. Financial Performance
      • 8.5.9.3. Product Benchmarking
      • 8.5.9.4. Strategic Initiatives
    • 8.5.10. Meridian Bioscience
      • 8.5.10.1. Overview
      • 8.5.10.2. Financial Performance
      • 8.5.10.3. Product Benchmarking
      • 8.5.10.4. Strategic Initiatives
    • 8.5.11. Fujirebio Diagnostics
      • 8.5.11.1. Overview
      • 8.5.11.2. Financial Performance
      • 8.5.11.3. Product Benchmarking
      • 8.5.11.4. Strategic Initiatives
    • 8.5.12. Cepheid
      • 8.5.12.1. Overview
      • 8.5.12.2. Financial Performance
      • 8.5.12.3. Product Benchmarking
      • 8.5.12.4. Strategic Initiatives
    • 8.5.13. Lumos Diagnostics
      • 8.5.13.1. Overview
      • 8.5.13.2. Financial Performance
      • 8.5.13.3. Product Benchmarking
      • 8.5.13.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviation
  • Table 3 Global Acute Respiratory Disease Diagnostics Market, By Region, 2021 - 2033 (USD Million)
  • Table 4 Global Acute Respiratory Disease Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 5 Global Acute Respiratory Disease Diagnostics Market, By Pathogen, 2021 - 2033 (USD Million)
  • Table 6 Global Acute Respiratory Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 7 North America Acute Respiratory Disease Diagnostics Market, By Country, 2021 - 2033 (USD Million)
  • Table 8 North America Acute Respiratory Disease Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 9 North America Acute Respiratory Disease Diagnostics Market, By Pathogen, 2021 - 2033 (USD Million)
  • Table 10 North America Acute Respiratory Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 11 U.S. Acute Respiratory Disease Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 12 U.S. Acute Respiratory Disease Diagnostics Market, By Pathogen, 2021 - 2033 (USD Million)
  • Table 13 U.S. Acute Respiratory Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 14 Canada Acute Respiratory Disease Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 15 Canada Acute Respiratory Disease Diagnostics Market, By Pathogen, 2021 - 2033 (USD Million)
  • Table 16 Canada Acute Respiratory Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 17 Mexico Acute Respiratory Disease Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 18 Mexico Acute Respiratory Disease Diagnostics Market, By Pathogen, 2021 - 2033 (USD Million)
  • Table 19 Mexico Acute Respiratory Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 20 Europe Acute Respiratory Disease Diagnostics Market, By Country, 2021 - 2033 (USD Million)
  • Table 21 Europe Acute Respiratory Disease Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 22 Europe Acute Respiratory Disease Diagnostics Market, By Pathogen, 2021 - 2033 (USD Million)
  • Table 23 Europe Acute Respiratory Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 24 UK Acute Respiratory Disease Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 25 UK Acute Respiratory Disease Diagnostics Market, By Pathogen, 2021 - 2033 (USD Million)
  • Table 26 UK Acute Respiratory Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 27 Germany Acute Respiratory Disease Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 28 Germany Acute Respiratory Disease Diagnostics Market, By Pathogen, 2021 - 2033 (USD Million)
  • Table 29 Germany Acute Respiratory Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 30 France Acute Respiratory Disease Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 31 France Acute Respiratory Disease Diagnostics Market, By Pathogen, 2021 - 2033 (USD Million)
  • Table 32 France Acute Respiratory Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 33 Italy Acute Respiratory Disease Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 34 Italy Acute Respiratory Disease Diagnostics Market, By Pathogen, 2021 - 2033 (USD Million)
  • Table 35 Italy Acute Respiratory Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 36 Spain Acute Respiratory Disease Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 37 Spain Acute Respiratory Disease Diagnostics Market, By Pathogen, 2021 - 2033 (USD Million)
  • Table 38 Spain Acute Respiratory Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 39 Denmark Acute Respiratory Disease Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 40 Denmark Acute Respiratory Disease Diagnostics Market, By Pathogen, 2021 - 2033 (USD Million)
  • Table 41 Denmark Acute Respiratory Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 42 Sweden Acute Respiratory Disease Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 43 Sweden Acute Respiratory Disease Diagnostics Market, By Pathogen, 2021 - 2033 (USD Million)
  • Table 44 Sweden Acute Respiratory Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 45 Norway Acute Respiratory Disease Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 46 Norway Acute Respiratory Disease Diagnostics Market, By Pathogen, 2021 - 2033 (USD Million)
  • Table 47 Norway Acute Respiratory Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 48 Asia Pacific Acute Respiratory Disease Diagnostics Market, By Country, 2021 - 2033 (USD Million)
  • Table 49 Asia Pacific Acute Respiratory Disease Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 50 Asia Pacific Acute Respiratory Disease Diagnostics Market, By Pathogen, 2021 - 2033 (USD Million)
  • Table 51 Asia Pacific Acute Respiratory Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 52 Japan Acute Respiratory Disease Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 53 Japan Acute Respiratory Disease Diagnostics Market, By Pathogen, 2021 - 2033 (USD Million)
  • Table 54 Japan Acute Respiratory Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 55 China Acute Respiratory Disease Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 56 China Acute Respiratory Disease Diagnostics Market, By Pathogen, 2021 - 2033 (USD Million)
  • Table 57 China Acute Respiratory Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 58 India Acute Respiratory Disease Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 59 India Acute Respiratory Disease Diagnostics Market, By Pathogen, 2021 - 2033 (USD Million)
  • Table 60 India Acute Respiratory Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 61 Australia Acute Respiratory Disease Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 62 Australia Acute Respiratory Disease Diagnostics Market, By Pathogen, 2021 - 2033 (USD Million)
  • Table 63 Australia Acute Respiratory Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 64 South Korea Acute Respiratory Disease Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 65 South Korea Acute Respiratory Disease Diagnostics Market, By Pathogen, 2021 - 2033 (USD Million)
  • Table 66 South Korea Acute Respiratory Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 67 Thailand Acute Respiratory Disease Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 68 Thailand Acute Respiratory Disease Diagnostics Market, By Pathogen, 2021 - 2033 (USD Million)
  • Table 69 Thailand Acute Respiratory Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 70 Latin America Acute Respiratory Disease Diagnostics Market, By Country, 2021 - 2033 (USD Million)
  • Table 71 Latin America Acute Respiratory Disease Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 72 Latin America Acute Respiratory Disease Diagnostics Market, By Pathogen, 2021 - 2033 (USD Million)
  • Table 73 Latin America Acute Respiratory Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 74 Brazil Acute Respiratory Disease Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 75 Brazil Acute Respiratory Disease Diagnostics Market, By Pathogen, 2021 - 2033 (USD Million)
  • Table 76 Brazil Acute Respiratory Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 77 Argentina Acute Respiratory Disease Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 78 Argentina Acute Respiratory Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 79 MEA Acute Respiratory Disease Diagnostics Market, By Country, 2021 - 2033 (USD Million)
  • Table 80 MEA Acute Respiratory Disease Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 81 MEA Acute Respiratory Disease Diagnostics Market, By Pathogen, 2021 - 2033 (USD Million)
  • Table 82 MEA Acute Respiratory Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 83 South Africa Acute Respiratory Disease Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 84 South Africa Acute Respiratory Disease Diagnostics Market, By Pathogen, 2021 - 2033 (USD Million)
  • Table 85 South Africa Acute Respiratory Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 86 Saudi Arabia Acute Respiratory Disease Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 87 Saudi Arabia Acute Respiratory Disease Diagnostics Market, By Pathogen, 2021 - 2033 (USD Million)
  • Table 88 Saudi Arabia Acute Respiratory Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 89 UAE Acute Respiratory Disease Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 90 UAE Acute Respiratory Disease Diagnostics Market, By Pathogen, 2021 - 2033 (USD Million)
  • Table 91 UAE Acute Respiratory Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 92 Kuwait Acute Respiratory Disease Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 93 Kuwait Acute Respiratory Disease Diagnostics Market, By Pathogen, 2021 - 2033 (USD Million)
  • Table 94 Kuwait Acute Respiratory Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Acute Respiratory Disease Diagnostics Market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modelling for market share assessment.
  • Fig. 8 Market formulation & validation
  • Fig. 9 Acute Respiratory Disease Diagnostics Market snapshot
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook.
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Acute Respiratory Disease Diagnostics Market driver impact
  • Fig. 14 Acute Respiratory Disease Diagnostics Market restraint impact
  • Fig. 15 SWOT analysis, by factor (political & legal, economic, and technological)
  • Fig. 16 Industry Analysis - Porter's
  • Fig. 17 Strategy mapping
  • Fig. 18 Acute Respiratory Disease Diagnostics Market: Test outlook and key takeaways
  • Fig. 19 Acute Respiratory Disease Diagnostics Market: Test movement analysis & market share 2024 & 2033
  • Fig. 20 Molecular Diagnostics Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 21 PCR Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 22 INAAT Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 23 Antigen-based Rapid Tests Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 24 Serological Tests (IgM/IgG) Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 25 Syndromic Respiratory Panels Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 26 Other Emerging Technologies (CRISPR-based, Nanopore Sequencing, AI-driven Imaging) Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 27 Acute Respiratory Disease Diagnostics Market: Pathogen outlook and key takeaways
  • Fig. 28 Acute Respiratory Disease Diagnostics Market: Pathogen movement analysis & market share 2024 & 2033
  • Fig. 29 Viral Infections Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 30 Influenza A & B Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 31 Respiratory Syncytial Virus (RSV) Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 32 SARS-CoV-2 Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 33 Others Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 34 Bacterial Infections Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 35 Streptococcus Pneumoniae Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 36 Haemophilus influenzae Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 37 Mycoplasma pneumoniae Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 38 Bordetella pertussis Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 39 Others Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 40 Acute Respiratory Disease Diagnostics Market: End Use outlook and key takeaways
  • Fig. 41 Acute Respiratory Disease Diagnostics Market: End Use movement analysis & market share 2024 & 2033
  • Fig. 42 Hospitals & Clinics Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 43 Diagnostic and Reference Labs Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 44 Home Testing Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 45 Others (Public health, surveillance labs) Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 46 Regional marketplace: Key takeaways
  • Fig. 47 Global Acute Respiratory Disease Diagnostics Market: Regional movement analysis
  • Fig. 48 U.S. Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 49 Canada Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 50 Mexico Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 51 Europe Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 52 UK Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 53 Germany Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 54 France Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 55 Italy Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 56 Spain Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 57 Denmark Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 58 Sweden Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 59 Norway Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 60 Asia Pacific Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 61 Japan Market Estimates and Forecast, 2021 - 2033(USD Million)
  • Fig. 62 China Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 63 India Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 64 South Korea Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 65 Australia Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 66 Thailand Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 67 Latin America Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 68 Brazil Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 69 Argentina Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 70 MEA Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 71 South Africa Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 72 Saudi Arabia Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 73 UAE Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 74 Kuwait Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 75 Strategy framework